XOMA-Logo-Final.png
XOMA Declares Quarterly Preferred Stock Dividends
21 juin 2021 07h30 HE | XOMA Corporation
EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to...
XOMA-Logo-Final.png
XOMA Licensees to Present Significant Clinical Data at 2021 ASCO Annual Meeting
21 mai 2021 08h00 HE | XOMA Corporation
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) recently learned its licensees are presenting at the upcoming 2021 American Society of Clinical Oncology (ASCO)...
XOMA-Logo-Final.png
XOMA Reports First Quarter 2021 Financial Results and Highlights Recent Operational Events
06 mai 2021 07h30 HE | XOMA Corporation
XOMA’s portfolio of potential milestone and royalty assets now has greater than 70 drug candidates.Company ended the first quarter of 2021 with $67.8 million in cash.  The April 2021 $40 million...
XOMA-Logo-Final.png
XOMA Earns Milestone for First Patient Dosed in Phase 3 Development Program
03 mai 2021 07h30 HE | XOMA Corporation
EMERYVILLE, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has earned a $0.5 million milestone from Janssen Biotech, Inc....
XOMA-Logo-Final.png
XOMA’s Royalty Portfolio Grows with Addition of Three Royalty Assets
15 avr. 2021 09h05 HE | XOMA Corporation
EMERYVILLE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) today announced its portfolio of potential future milestone and royalty assets has increased with the addition...
XOMA-Logo-Final.png
XOMA Announces Closing of Depositary Shares Offering and Exercise of Underwriters’ Option
12 avr. 2021 07h30 HE | XOMA Corporation
Raised aggregate gross proceeds of $40 million Depositary shares represent an interest in 8.375% Series B Cumulative Perpetual Preferred Stock EMERYVILLE, Calif., April 12, 2021 (GLOBE NEWSWIRE)...
XOMA-Logo-Final.png
XOMA Prices $35 Million Offering of Depositary Shares
06 avr. 2021 19h02 HE | XOMA Corporation
EMERYVILLE, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the pricing of its underwritten registered public offering of...
XOMA-Logo-Final.png
XOMA Announces Offering of Depositary Shares and Series B Cumulative Perpetual Preferred Stock
05 avr. 2021 16h05 HE | XOMA Corporation
EMERYVILLE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has commenced an underwritten registered public offering of...
XOMA-Logo-Final.png
XOMA Announces Approval of First Preferred Stock Dividend
22 mars 2021 07h30 HE | XOMA Corporation
EMERYVILLE, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors approved a dividend of $0.71875 per share to...
XOMA-Logo-Final.png
XOMA Reports Fourth Quarter and Full-Year 2020 Financial Results and Operating Highlights
10 mars 2021 07h30 HE | XOMA Corporation
Recognized revenue of $29.4 million Six assets in the Company’s milestone and royalty portfolio advanced to Phase 2 clinical development Completed $24.6 million Series A Perpetual Preferred Stock...